Glycine for Racing Thoughts and Fragmented Sleep: Evidence, Effective Dosing, and Next-Day Cognitive Effects

Racing thoughts at night can feel like your brain is “stuck on,” and fragmented sleep often makes the next day’s focus, memory, and emotional regulation worse. Glycine—a simple amino acid that also functions as a neurotransmitter—has clinical evidence for improving subjective sleep quality and next-day alertness in some people, especially when sleep is shortened or disrupted (Yamadera et al., 2007; Inagawa et al., 2006). This article breaks down what the research says about glycine for sleep-onset anxiety-like rumination, effective dosing, and what to expect cognitively the next day.

What Glycine Does in the Brain (and Why It Matters for Racing Thoughts)

Glycine is both (1) an inhibitory neurotransmitter in the spinal cord and brainstem and (2) a key “co-agonist” at NMDA receptors in the brain, meaning it helps regulate glutamatergic signaling involved in learning, arousal, and cognitive flexibility (Johnson & Ascher, 1987; Nishikawa, 1994). Because hyperarousal and rumination are core features of insomnia and anxiety-spectrum sleep disruption, interventions that shift the nervous system toward a calmer physiological state can indirectly reduce “racing thoughts” at bedtime (Riemann et al., 2010).

One proposed sleep mechanism is thermoregulation: glycine appears to facilitate heat loss and lower core body temperature, a normal biological step that supports sleep initiation and continuity (Kawai et al., 2015). Since difficulty “switching off” is often paired with elevated physiological arousal (e.g., tension, restlessness, feeling warm), this cooling-related pathway is clinically relevant for fragmented sleep (Riemann et al., 2010; Kawai et al., 2015).

What this means for mental wellness

Glycine is not a sedative in the way many sleep medications are; instead, the evidence suggests it may improve perceived sleep quality and next-day functioning by supporting sleep physiology (especially under restricted sleep) rather than forcing sleep (Yamadera et al., 2007; Inagawa et al., 2006). For people whose racing thoughts worsen when sleep becomes lighter and more fragmented, improving sleep depth/continuity can reduce next-day anxiety sensitivity and cognitive “noise” (Riemann et al., 2010).

Evidence for Glycine and Sleep: What Human Studies Show

Human trials have most commonly tested oral glycine at bedtime and measured subjective sleep quality and next-day performance. In adults reporting sleep complaints, glycine taken before bed improved subjective sleep quality measures compared with placebo in controlled trials (Yamadera et al., 2007). In additional experimental work, glycine has been studied during partial sleep restriction—a model that mimics the “fragmented/too-short sleep” many people experience during stress—and was associated with improvements in next-day fatigue and sleepiness outcomes (Inagawa et al., 2006).

It’s important to set expectations: not all studies find large changes in objective sleep architecture (like polysomnography-derived staging) in every population, and benefits may be more noticeable in perceived sleep depth, sleep satisfaction, and daytime functioning (Yamadera et al., 2007; Inagawa et al., 2006). That profile still matters for mental health, because subjective sleep quality strongly tracks mood symptoms, irritability, and cognitive efficiency in day-to-day life (Buysse et al., 1989; Riemann et al., 2010).

Bottom line from the evidence

• Glycine has randomized, placebo-controlled human evidence for improving subjective sleep quality in people with sleep complaints (Yamadera et al., 2007).
• Under sleep restriction, glycine has been linked to less next-day sleepiness/fatigue and better daytime functioning outcomes (Inagawa et al., 2006).
• Mechanistic work supports thermoregulatory and neurochemical plausibility for sleep benefits (Kawai et al., 2015; Johnson & Ascher, 1987).

Effective Dosing, Timing, and How to Trial It Safely

Across published human sleep studies, a common research dose is 3 grams of glycine taken before bedtime (Yamadera et al., 2007; Inagawa et al., 2006). This dosing is practical (powder mixes easily), and it matches the range most often associated with sleep-quality improvements in the literature (Yamadera et al., 2007).

How to run a simple 10–14 day “N-of-1” sleep trial

• Start dose: 3 g glycine, 30–60 minutes before bed (Yamadera et al., 2007).
• Track sleep: nightly sleep onset latency, number of awakenings, and a 1–10 sleep quality rating (Buysse et al., 1989).
• Track daytime cognition: morning sleepiness (1–10), mid-day focus (1–10), and reaction-time/attention using a consistent digital test (Inagawa et al., 2006).
• Keep variables stable: caffeine cutoff time, alcohol intake, bedtime, and screen exposure—because these can overwhelm supplement effects in insomnia (Riemann et al., 2010).

If glycine helps, the most consistent early signs reported in trials are better perceived sleep depth/quality and improved next-day freshness rather than a dramatic “knockout” effect at bedtime (Yamadera et al., 2007; Inagawa et al., 2006). If you notice worse sleep or unusual dreams/arousal, discontinue and reassess; insomnia is a heterogeneous condition, and responses to sleep aids can vary meaningfully across individuals (Riemann et al., 2010).

Next-Day Cognitive Effects: Alertness, Fatigue, and Performance

Fragmented sleep tends to impair attention, working memory, and emotional control the next day—domains tightly linked to mental well-being and anxiety resilience (Killgore, 2010). In sleep-restriction experiments, bedtime glycine has been associated with improved next-day sleepiness and fatigue measures, suggesting it may support daytime cognitive functioning when sleep is short (Inagawa et al., 2006). Separate controlled work in individuals with sleep complaints also reported improved subjective sleep outcomes consistent with better daytime functioning (Yamadera et al., 2007).

Practically, this matters because many people pursue sleep supplements not only to fall asleep, but to reduce next-day “brain fog,” irritability, and reduced productivity—common cognitive and mood sequelae of insomnia (Riemann et al., 2010; Killgore, 2010). If glycine improves perceived sleep depth or reduces nocturnal awakenings, the downstream effect can be better alertness and steadier cognitive performance, particularly on sustained attention tasks (Inagawa et al., 2006; Killgore, 2010).

Pairing glycine with evidence-based sleep strategies

Supplements work best when layered onto behavioral approaches with strong evidence for insomnia and pre-sleep rumination. Cognitive behavioral therapy for insomnia (CBT-I) is considered a first-line treatment for chronic insomnia and has robust evidence for improving sleep and daytime functioning (Trauer et al., 2015). If racing thoughts are prominent, combining CBT-I tools (stimulus control, sleep restriction, cognitive restructuring) with a short glycine trial may be more effective than relying on supplements alone (Trauer et al., 2015; Riemann et al., 2010).

Who Should (and Shouldn’t) Use Glycine for Sleep and Mental Calm

Glycine may be most relevant for adults with mild-to-moderate sleep complaints, stress-related sleep restriction, or fragmented sleep where next-day fatigue and cognitive inefficiency are the primary complaints (Yamadera et al., 2007; Inagawa et al., 2006). Because insomnia often involves hyperarousal biology, any intervention that improves sleep continuity can support mood regulation and cognitive performance indirectly (Riemann et al., 2010; Killgore, 2010).

Situations where extra caution is warranted

• If you have a diagnosed psychiatric condition (e.g., bipolar disorder, severe anxiety, major depression) and are changing sleep interventions: insomnia treatment can influence mood stability, so coordinate changes with a clinician (Riemann et al., 2010; Trauer et al., 2015).
• If you use sedatives or sleep medications: combining agents can change next-day alertness and safety-sensitive performance; clinical oversight is recommended (Riemann et al., 2010).
• If your “racing thoughts” include panic, trauma symptoms, or intrusive thoughts: CBT-I and targeted therapy can address underlying drivers more directly than supplements (Trauer et al., 2015).

For baseline assessment and progress, validated sleep measures (like the Pittsburgh Sleep Quality Index) are useful for tracking clinically meaningful change over time (Buysse et al., 1989). If sleep remains fragmented for more than 3 months or is accompanied by severe daytime impairment, professional evaluation is important to rule out conditions like sleep apnea or comorbid anxiety disorders (Riemann et al., 2010).

Conclusion

Glycine has placebo-controlled human evidence—most often at 3 g before bed—for improving subjective sleep quality and reducing next-day sleepiness/fatigue, particularly when sleep is shortened or disrupted (Yamadera et al., 2007; Inagawa et al., 2006). While it isn’t a stand-alone fix for chronic insomnia or anxiety-driven rumination, it may be a reasonable, evidence-based supplement trial when fragmented sleep is driving next-day cognitive fog and emotional reactivity (Riemann et al., 2010; Killgore, 2010). For sustained change, consider pairing any supplement approach with CBT-I, which has strong evidence for improving sleep and daytime functioning (Trauer et al., 2015).

References

• Buysse, D. J., Reynolds, C. F., Monk, T. H., Berman, S. R., & Kupfer, D. J. (1989). The Pittsburgh Sleep Quality Index: A new instrument for psychiatric practice and research. Psychiatry Research, 28(2), 193–213. https://doi.org/10.1016/0165-1781(89)90047-4
• Inagawa, K., Hiraoka, T., Kohda, T., Yamadera, W., Takahashi, M., & Kawai, N. (2006). Subjective effects of glycine ingestion before bedtime on sleep quality. Sleep and Biological Rhythms, 4(1), 75–77. https://doi.org/10.1111/j.1479-8425.2006.00193.x
• Johnson, J. W., & Ascher, P. (1987). Glycine potentiates the NMDA response in cultured mouse brain neurons. Nature, 325(6104), 529–531. https://doi.org/10.1038/325529a0
• Kawai, N., Sakai, N., Okuro, M., Karakawa, S., Tsuneyoshi, Y., Kawasaki, N., & Takahashi, H. K. (2015). The sleep-promoting and hypothermic effects of glycine are mediated by NMDA receptors in the suprachiasmatic nucleus. Neuropsychopharmacology, 40(6), 1405–1416. https://doi.org/10.1038/npp.2014.326
• Killgore, W. D. S. (2010). Effects of sleep deprivation on cognition. Progress in Brain Research, 185, 105–129. https://doi.org/10.1016/B978-0-444-53702-7.00007-5
• Nishikawa, T. (1994). Roles of glycine in the NMDA receptor channel complex and the psychotomimetic action of phencyclidine. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 18(5), 885–914. https://doi.org/10.1016/0278-5846(94)90027-2
• Riemann, D., Spiegelhalder, K., Feige, B., Voderholzer, U., Berger, M., Perlis, M., & Nissen, C. (2010). The hyperarousal model of insomnia: A review of the concept and its evidence. Sleep Medicine Reviews, 14(1), 19–31. https://doi.org/10.1016/j.smrv.2009.04.002
• Trauer, J. M., Qian, M. Y., Doyle, J. S., Rajaratnam, S. M. W., & Cunnington, D. (2015). Cognitive behavioral therapy for chronic insomnia: A systematic review and meta-analysis. Annals of Internal Medicine, 163(3), 191–204. https://doi.org/10.7326/M14-2841
• Yamadera, W., Inagawa, K., Chiba, S., Bannai, M., Takahashi, M., & Nakayama, K. (2007). Glycine ingestion improves subjective sleep quality in human volunteers, correlating with polysomnographic changes. Sleep and Biological Rhythms, 5(2), 126–131. https://doi.org/10.1111/j.1479-8425.2007.00262.x

Read more evidence-based supplement guides and brain-health tools at https://strongerminded.com